Navigation Links
New Study Explores Medical Affairs Capabilities in Mature and High-Growth Markets
Date:8/23/2013

And Top Current Challenges Regarding Global & Indian Medical Affairs.
  • Identify What Percentage Of Medical Affairs Budget Leading Companies Allocate To Outsourcing.
  • Trace How Successful Medical Affairs Organizations Work Cross-Functionally To Enhance Effectiveness.
  • This benchmarking research drew participation from 68 Medical Affairs leaders at 50 top pharmaceutical and medical device companies across mature global markets. In addition, the study presents a segment from India-based organizations.

    To access the full report, or to download a complimentary summary containing insights found in this report, click on the following link: http://www.best-in-class.com/rr1230.htm.

    For more information on other recent primary research studies, contact us at 919.403.0251, or visit our website at http://www.best-in-class.com/.

    ABOUT BEST PRACTICES, LLC

    Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.


    '/>"/>
    SOURCE Best Practices, LLC
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2

    Related medicine technology :

    1. Study of Mechanism of Action of Ibrutinib in Mantle Cell Lymphoma Published in Blood - Journal of the American Society of Hematology
    2. Final Patient Completes Prosonix Phase 2 Clinical Study with PSX1002 in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
    3. Boehringer Ingelheim Announces Agreement to Study Real-World Use of Oral Anticoagulants
    4. Celsion Corporation Reports Second Quarter 2013 Financial Results and Provides HEAT Study Update
    5. Isis Pharmaceuticals Reports Data From a Phase 2 Study of Isis-CRP Rx in Patients with Rheumatoid Arthritis
    6. GW Pharmaceuticals Announces Results of MS Spasticity Study Confirming Sativex Has No Long-Term Negative Effect on Cognition
    7. Astellas Confirms Interim Analysis in PREVAIL Study of XTANDI will Occur within Calendar Year 2013
    8. Physicians Expect More Out of Tablet-Toting Pharmaceutical Sales Reps, Study Finds
    9. Nektar Completes Enrollment in Phase 3 BEACON Study of Etirinotecan Pegol in Women With Metastatic Breast Cancer
    10. Mechanism for Cardiac Effects of Trevena Angiotensin Receptor Biased Ligands Examined in Published Study
    11. EntreMed Initiates Crossover Bioavailability And Food Effect Study Of ENMD-2076 Dosage Form To Be Used For Pivotal/Registration Clinical Trials
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/5/2015)... -- AMRI (NASDAQ: AMRI ) announced today that ... of VP of International Sales, effective immediately. He reports ... Global Sales and Marketing. In this ... in an effort to increase worldwide customer value and ... will drive strategy for sales and marketing efforts across ...
    (Date:3/5/2015)... , March 5, 2015 LUNGevity ... the Food and Drug Administration,s (FDA) approval of ... Opdivo and other immunotherapy treatments add another critical ... harnessing the power of a patient,s own immune ... has been approved specifically for patients with squamous ...
    (Date:3/5/2015)... 2015 Research and Markets ( ... "Global Pharma US & EU Outlook 2015: ... Role In Shaping Up Business for Large Cap ... Strategy Diversification Divested: Productivity measurements, Divestment ... Will accelerate Next wave of targeted acquisition ...
    Breaking Medicine Technology:AMRI Hires VP of International Sales 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 2Global Pharma US & EU Outlook 2015: First -In-Class Innovations and Cost Optimization Plays Major Role In Shaping Up Business for Large Cap Pharmaceutical Companies 3
    ... Inc. (NASDAQ: OPTR ) today announced the ... of Research and Development, Cynthia Schwalm as Senior Vice ... Vice President of Pharmacovigilance. These newly created positions will ... for the potential launch of its lead product candidate, ...
    ... MOUNTAIN VIEW, Calif., May 3, 2011 Alexza Pharmaceuticals, ... today announced that it has entered into a definitive ... and Tavistock Life Sciences, to raise approximately $16.1 million ... the sale of common stock and warrants.  The Company ...
    Cached Medicine Technology:Optimer Pharmaceuticals Expands Senior Management Team 2Optimer Pharmaceuticals Expands Senior Management Team 3Optimer Pharmaceuticals Expands Senior Management Team 4Optimer Pharmaceuticals Expands Senior Management Team 5Alexza Prices $16.1 Million Registered Direct Offering 2Alexza Prices $16.1 Million Registered Direct Offering 3Alexza Prices $16.1 Million Registered Direct Offering 4
    (Date:3/6/2015)... As the Mayo Clinic's 2012 published Benicar ... Associates Nationwide Legal Services, A.P.C., comments on these findings ... v. Daiichi Sankyo, Inc., Case No. 3:15-cv-159, in US ... light of a recently filed lawsuit, Ford & Associates ... explore the Mayo Clinic's Benicar case study findings purportedly ...
    (Date:3/5/2015)... digital PCR (dPCR) and qPCR market is expected to reach $3.97 ... , The global digital PCR (dPCR) and qPCR market is estimated ... Although the mature markets such as the U.S., Germany, France and ... market the Asia-Pacific region is expected to grow at the highest ... digital PCR (dPCR) and qPCR market is driven by factors such ...
    (Date:3/5/2015)... 05, 2015 AxoGen, Inc. (NASDAQ: ... the peripheral nerve repair market, reported record revenue of ... 2014 compared to $2.98 million in the year-ago fourth ... strategies. , “Our strong fourth quarter revenue growth ... repair products which is driving increased surgeon adoption of ...
    (Date:3/5/2015)... Rhode Island Medical Imaging (RIMI) was pleased to donate ... the Providence College (PC) women’s basketball program’s fight to end ... ‘Think Pink’ uniforms, which were worn during the February 22nd ... at Alumni Hall/Mullaney Gymnasium in Providence, R.I. , ... women’s basketball’s ‘Pink Out’ event,” said Dr. Scott Levine of ...
    (Date:3/5/2015)... 05, 2015 SuperCloset has released a new ... series aims to teach viewers everything they need to know ... Like a SuperPro takes you from seed all the way ... clone, to how to prune Grow Like a SuperPro will ... the whole series for download for a special introductory price ...
    Breaking Medicine News(10 mins):Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 2Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 3Health News:Mayo Clinic's Benicar Case Study Findings Prompts Commentary from Ford & Associates Nationwide Legal Services in Wake of a Recently Filed Benicar Lawsuit 4Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 2Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 3Health News:New Research Report by MarketsandMarkets on Digital PCR and qPCR Market Worth $3.97 Billion by 2019 4Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 2Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 3Health News:AxoGen, Inc. Reports 61% Revenue Growth for the 2014 Fourth Quarter 4Health News:RIMI Teams Up with PC Women’s Basketball in the Fight Against Breast Cancer 2
    ... HOFFMAN ESTATES, Ill., Sept. 9 Kmart announced today that its ... continue through October 30, 2009. Seasonal flu vaccinations will be ... supplies last. , , "Kmart Pharmacy ... Ayshford, RPh, divisional vice president, Kmart Pharmacy. "Due to continuing concern ...
    ... Sept. 9 On Thursday, September 10 at 8:30 p.m. ET, ... will host a special one hour "National Townhall on Health Care ... Congressional leaders and policy experts to discuss the moral, ethical, and financial ... Webcast viewers will be able to: , * get ...
    ... to take up more of the American economy in the future, ... health care is growing so fast that it will devour much ... larger chunks out of personal income, a new study warns. ... for more than half of the increases in the salary that ...
    ... Industries Ltd. (NYSE: NBR ) invites you to join Eugene M. Isenberg, Chairman and ... third quarter 2009. Nabors will release earnings after the market closes on October 20, 2009. , ... October 21, 2009, Time: ... a.m. ET), Dial-in-number:, Domestic: ...
    ... NEW YORK A new type of stem cell ... a source of prostate cancer, according to a new ... Center at Columbia University Medical Center and NewYork-Presbyterian Hospital. ... and genetics and development at Columbia University Medical Center, ...
    ... following two issuers (HTDS) www.htdsmedical.com and (LDSR) ... previous news releases announcing their aspirations of becoming a ... retained an SEC qualified auditor for the aforementioned purpose. ... is providing this notice to the issuers followers and ...
    Cached Medicine News:Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 2Health News:Kmart Pharmacy Flu Clinics Begin September 10, 2009 3Health News:New type of adult stem cells found in the prostate may be involved in prostate cancer development 2Health News:Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors 2Health News:Hard to Treat Diseases, Inc. (HTDS) and Landstar Inc (LDSR) Retain Auditors 3
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    Medicine Products: